Pestilence And Profit

Kelly, Tim; Schoenberger, Chana R.
June 2009
Forbes Asia;6/8/2009, Vol. 5 Issue 10, p14
The article focuses on the H1N1 swine flu in Japan and the profits incurred by Japanese pharmaceutical company Chugai Pharmaceutical Co. Ltd. It is stated that the Japanese government has stockpiled 340 million tablets of the antiviral flu remedy Tamiflu, which is made by Chugai. Chugai is reportedly expecting to benefit from the situation as the demand for Tamiflu increases. The impact of a flu pandemic on Japan is discussed.


Related Articles

  • H1N1dsight is a wonderful thing.  // Nature Biotechnology;Mar2010, Vol. 28 Issue 3, p182 

    The article reflects on the criticisms of the responses of governments and the pharmaceutical industry to the threat of the pandemic of influenza strain H1N1. The death toll due to the swine flu is said to be lower than seasonal influenza in the U.S. The European governments had allegedly...

  • Swine flu is not just a hoax by Big Pharma. MacKenzie, Debora // New Scientist;1/23/2010, Vol. 205 Issue 2744, p11 

    The article discusses various issues concerning the H1N1 influenza pandemic. There were claims that the H1N1 pandemic received an overreaction from health authorities as a conspiracy act for the big pharmaceutical companies. The author argues that the reality of the pandemic is beyond the...

  • Seasonal vaccine production at risk.  // Pulse;5/6/2009, Vol. 69 Issue 15, p4 

    The article reports that seasonal vaccine production may be at risk in case an influenza pandemic may be declared in Great Britain. It states that in case of an influenza outbreak, the government may require pharmaceutical companies to stop the production of seasonal flu vaccine and concentrate...

  • The problem with flu vaccines. Jack, Andrew // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/30/2009, Vol. 338 Issue 7706, p1298 

    The article speculates on the capability of the pharmaceutical industry to create enough vaccines to address the swine flu pandemic. The advent and global spread of swine flu have raised scientific uncertainties and technical problems, as well as issues on whether commercial manufacturers can...

  • How soon until a swine flu vaccine? Ryan, Jeff; Skernivitz, Stephanie // Contemporary Pediatrics;Jun2009, Vol. 26 Issue 6, p24 

    The article assesses the possibility of having vaccines for influenza H1N1. It cites the order by the World Health Organization (WHO) for pharmaceutical companies to prepare to make a possible pandemic level of swine flu doses, which would be about two billion doses. According to the article,...

  • Preventing pandemics of panic in a NICE way. Bonneaux, Luc; Van Damme, Wim // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/12/2010, Vol. 340 Issue 7759, p1308 

    The authors propose ways to prevent panic during pandemics. They argue that the global plans to control epidemic threats and iatrogenic pandemics of panic are waste of money. They claim that the scarcity in resources influenced the health economics and health policy issues surrounding global...

  • A false pandemic? Kondro, Wayne // CMAJ: Canadian Medical Association Journal;3/9/2010 Supplement, Vol. 182, pE209 

    The article reports on the sessions that will be conducted by the Parliamentary Assembly of the Council of Europe (PACE). It states that the PACE will conduct sessions on whether the pharmaceutical industry unduly influenced the World Health Organization's (WHO) decision in declaring swine flu a...

  • Emergency plans for pandemic get live test.  // Hospital Home Health;Jun2009, Vol. 26 Issue 6, p64 

    No abstract available.

  • HIV clinicians and patients should prepare now for fall pandemic flu.  // AIDS Alert;Jun2009, Vol. 24 Issue 6, p61 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics